Novo Nordisk
Danish pharmaceutical company deploying enterprise AI and accelerated-computing infrastructure across drug discovery, R&D, and manufacturing.
- Company type
- Global pharmaceutical company
- Headquarters
- Bagsværd, Denmark
- Website
- https://www.novonordisk.com
- Profile last verified
- 2026-07-29
AI Partnerships & Deployments
- 2026-04-14 — Enterprise-wide alliance with OpenAI (OpenAI). Novo Nordisk and OpenAI partnered on an enterprise-wide alliance spanning R&D, workforce, and manufacturing, aiming to create customized AI models and agents for early research and clinical development. Financial terms were not disclosed. Source: BioSpace (press release) (accessed 2026-07-29)
- 2025-06-11 — Drug-discovery collaboration with NVIDIA using BioNeMo (NVIDIA (BioNeMo)). NVIDIA collaboration accelerating drug-discovery use cases, supporting Novo Nordisk's agreement with the Danish Centre for AI Innovation (DCAI) to use the Gefion sovereign AI supercomputer together with NVIDIA's BioNeMo, NIM/NeMo microservices, and Omniverse. Financial terms were not disclosed. Source: NVIDIA newsroom (accessed 2026-07-29)